Obstructive sleep apnea is associated with increased atrial fibrillation recurrence after ablation in patients with paroxysmal atrial fibrillation.

VANCOUVER, BC — Ten-year results from the Canadian Registry of Atrial Fibrillation (CARAF) of more than 700 patients with paroxysmal AF showed that only 36% of patients went on to have persistent AF ...

BIRMINGHAM, UK — Patients with paroxysmal atrial fibrillation (AF) were substantially less likely to be treated with oral anticoagulants than patients with persistent AF or permanent AF in a cohort ...

Please provide your email address to receive an email when new articles are posted on . The number of patients with paroxysmal atrial fibrillation who are prescribed anticoagulants has increased, but ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. More than 40% of patients with paroxysmal atrial ...

DALLAS, TX—In patients with paroxysmal atrial fibrillation (A-fib), treatment with high frequency (HF) source ablation failed to meet noninferiority criteria compared with circumferential pulmonary ...

The recurrence of atrial fibrillation (AF) after catheter ablation occurs in 11% to 41% of patients. 1 A recent study by Masuda and colleagues 2 reports that the presence of left atrial low-voltage ...

Yoga improves quality of life in patients with paroxysmal atrial fibrillation, according to research. Heart rate and blood pressure also decreased in patients who did yoga. Yoga improves quality of ...

Credit: Getty Images A discussion on the use of pulsed field ablation for paroxysmal and persistent atrial fibrillation with Andrea Natale, MD, FACC. In December 2023, the PulseSelect pulsed field ...

Researchers have found that asymptomatic paroxysmal atrial fibrillation (AF) patients are more likely to be older, male, and have more comorbidities and a higher risk of stroke than symptomatic ...

Using cryoablation as first-line therapy in patients with newly diagnosed, paroxysmal atrial fibrillation can significantly reduce the risk of recurrence measured by continuous arrhythmia monitoring ...

- FARAPULSE becomes first company in the world to commercialize a cardiac PFA system - MENLO PARK, Calif., Jan. 29, 2021 /CNW/ - FARAPULSE Inc. ("FARAPULSE" or "the Company") today announced that it ...